Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M92,652Revenue $M19,616Net Margin (%)11.2Altman Z-Score4.3
Enterprise Value $M96,760EPS $2.2Operating Margin %16.0Piotroski F-Score4
P/E(ttm)42.1Beneish M-Score-2.6Pre-tax Margin (%)13.9Higher ROA y-yN
Price/Book6.410-y EBITDA Growth Rate %10.8Quick Ratio1.1Cash flow > EarningsY
Price/Sales4.75-y EBITDA Growth Rate %-6.0Current Ratio1.4Lower Leverage y-yN
Price/Free Cash Flow38.8y-y EBITDA Growth Rate %-32.9ROA % (ttm)6.2Higher Current Ratio y-yN
Dividend Yield %2.3PEG--ROE % (ttm)13.0Less Shares Outstanding y-yY
Payout Ratio %96.0Shares Outstanding M1,110ROIC % (ttm)13.7Gross Margin Increase y-yN

Gurus Latest Trades with LLY

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
LLYVanguard Health Care Fund 2015-03-31 Add0.45%$68.41 - $76.36
($71.19)
$ 86.1421%Add 13.24%24,892,160
LLYCharles Brandes 2015-03-31 Reduce-0.06%$68.41 - $76.36
($71.19)
$ 86.1421%Reduce 36.80%107,025
LLYKen Fisher 2015-03-31 Add0.03%$68.41 - $76.36
($71.19)
$ 86.1421%Add 37.46%795,909
LLYHOTCHKIS & WILEY 2015-03-31 Add0.01%$68.41 - $76.36
($71.19)
$ 86.1421%Add 0.70%3,968,039
LLYJoel Greenblatt 2015-03-31 Sold Out -0.0031%$68.41 - $76.36
($71.19)
$ 86.1421%Sold Out0
LLYDodge & Cox 2015-03-31 Reduce$68.41 - $76.36
($71.19)
$ 86.1421%Reduce 7.10%36,234
LLYMario Gabelli 2015-03-31 Reduce$68.41 - $76.36
($71.19)
$ 86.1421%Reduce 1.76%111,800
LLYCharles Brandes 2014-12-31 Reduce-1.85%$61.9 - $72.83
($67.53)
$ 86.1428%Reduce 92.65%169,348
LLYRichard Pzena 2014-12-31 Sold Out -0.15%$61.9 - $72.83
($67.53)
$ 86.1428%Sold Out0
LLYKen Fisher 2014-12-31 Add0.07%$61.9 - $72.83
($67.53)
$ 86.1428%Add 383.26%578,992
LLYCharles Brandes 2014-09-30 Reduce-0.29%$60.35 - $66.59
($63.3)
$ 86.1436%Reduce 14.27%2,303,062
LLYHOTCHKIS & WILEY 2014-09-30 Reduce-0.12%$60.35 - $66.59
($63.3)
$ 86.1436%Reduce 10.92%4,321,666
LLYGeorge Soros 2014-09-30 Sold Out -0.02%$60.35 - $66.59
($63.3)
$ 86.1436%Sold Out0
LLYDavid Dreman 2014-09-30 Reduce-0.02%$60.35 - $66.59
($63.3)
$ 86.1436%Reduce 84.40%900
LLYKen Fisher 2014-09-30 Add0.02%$60.35 - $66.59
($63.3)
$ 86.1436%Add 2742.47%119,810
LLYJoel Greenblatt 2014-09-30 Reduce$60.35 - $66.59
($63.3)
$ 86.1436%Reduce 27.37%5,628
LLYDodge & Cox 2014-09-30 Add$60.35 - $66.59
($63.3)
$ 86.1436%Add 20.38%42,464
LLYHOTCHKIS & WILEY 2014-06-30 Add0.73%$58.21 - $63.1
($59.62)
$ 86.1444%Add 199.70%4,851,480
LLYVanguard Health Care Fund 2014-06-30 Reduce-0.15%$58.21 - $63.1
($59.62)
$ 86.1444%Reduce 3.98%21,982,700
LLYGeorge Soros 2014-06-30 Buy 0.02%$58.21 - $63.1
($59.62)
$ 86.1444%New holding50,441
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

LLY is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


LLY: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
LILLY ENDOWMENT INC10% Owner 2015-06-10Sell210,000$82.394.55view
LILLY ENDOWMENT INC10% Owner 2015-06-04Sell200,000$77.910.58view
Simmons Jeffrey NSVP&Pres. Elanco Animal Health 2015-05-29Sell20,000$78.0810.32view
Zakrowski Donald AChief Accounting Officer 2015-05-29Sell200$78.339.97view
LILLY ENDOWMENT INC10% Owner 2015-05-20Sell190,000$73.4317.31view
LILLY ENDOWMENT INC10% Owner 2015-05-15Sell200,000$72.8318.28view
LILLY ENDOWMENT INC10% Owner 2015-05-08Sell195,000$73.2817.55view
LILLY ENDOWMENT INC10% Owner 2015-05-01Sell200,000$73.0917.85view
LILLY ENDOWMENT INC10% Owner 2015-03-30Sell180,000$73.9416.5view
LILLY ENDOWMENT INC10% Owner 2015-03-23Sell190,000$76.9711.91view

Quarterly/Annual Reports about LLY:

News about LLY:

Articles On GuruFocus.com
Bristol-Myers Squibb Takes A Step Up On Cancer Drugs, But The Cost Tells A Different Story Jun 22 2015 
Activist Hedge Fund Manager Has Strong Focus on Health Care Stocks Jun 11 2015 
Abbvie Inc. Dividend Stock Analysis May 26 2015 
Biogen Making A Breakthrough In Treating Alzheimer’s May 02 2015 
MannKind Looks Good For Long Term Investors Apr 29 2015 
What Are The Intrinsic Factors Contributing To Pfizer’s Stock Movement? Mar 27 2015 
Eli Lilly Inks Major Deal In China To Develop Oncology Segment Mar 23 2015 
Box Inc. Declares Mixed Bag Q4 Results for 2015 Mar 13 2015 
Primecap Management's Annual Shareholder Letter 2014 Mar 09 2015 
FDA Approves Sanofi’s New Diabetes Drug Feb 27 2015 

More From Other Websites
4 Merrill Lynch Catalyst-Driven Stock Ideas to Buy Now Jul 02 2015
Lilly Confirms Date and Conference Call for Second-Quarter 2015 Financial Results Announcement Jul 01 2015
Lilly Confirms Date and Conference Call for Second-Quarter 2015 Financial Results Announcement Jul 01 2015
Pharma groups eye healthy returns from animal drugs market Jul 01 2015
Eli Lilly (LLY) Stock Price Target Raised at Leerink Jun 29 2015
Lilly is Fined by Brazil for 'Sham' Litigation Over a Cancer Drug Patent Jun 29 2015
Lilly and Immunocore Announce Immunotherapy-based Clinical Trial Collaboration in Melanoma Jun 29 2015
Lilly and Immunocore Announce Immunotherapy-based Clinical Trial Collaboration in Melanoma Jun 29 2015
Eli Lilly and Immunocore in cocktail collaboration against cancer Jun 29 2015
Immunocore and Lilly Announce Immunotherapy-Based Clinical Trial Collaboration in Melanoma Jun 29 2015
Eli Lilly Wins Alimta Patent Lawsuit in the UK, Shares Up - Analyst Blog Jun 26 2015
Is Big Pharma Advertising Getting Out of Control? Jun 26 2015
Are Cancer Drugs Becoming Too Costly for Their Effectiveness? Jun 26 2015
Eli Lilly (LLY) Stock Up Following Price Target Boost Jun 26 2015
What You May Have Missed In Biotech: Cancer-Killing T-Cells, Hope For Migraines, CRISPR Controversy Jun 26 2015
Deep in ‘the Cave,' Lilly's CEO Decided Alzheimer's Drug's Fate Jun 26 2015
Adocia and Lilly report positive Phase 1b topline results on the post-meal effect of ultra-rapid... Jun 26 2015
Eli Lilly wins UK Alimta drug patent case on appeal, shares jump Jun 25 2015
Eli Lilly Shares Go Parabolic Jun 25 2015
Lilly Blooms; Shares Up 4.5% on Patent Win, Merrill Upgrade Jun 25 2015

Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK